You have 9 free searches left this month | for more free features.

immune modulators

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stress Trial in Plymouth (Chaga Mushroom, Algae Extract, Black Cumin Seed Oil)

Completed
  • Stress
  • Chaga Mushroom
  • +5 more
  • Plymouth, Massachusetts
    3 Waves Wellness, LLC
Aug 18, 2022

COVID-19 Trial in Viña Del Mar (MC 3x3, Placebo)

Not yet recruiting
  • COVID-19
  • MC 3x3
  • Placebo
  • Viña Del Mar, Valparaiso, Chile
    Hospital Gustavo Fricke
Jul 18, 2022

MS Patients Treated With Sphingosine-1-phosphate Receptor

Recruiting
  • Multiple Sclerosis
  • S1PR analysis on immune cells
  • Bern, Switzerland
    Neurology department
Apr 12, 2023

Cancer Trial in Toronto (Nurse Monitoring)

Not yet recruiting
  • Cancer
  • Nurse Monitoring
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 21, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Systemic Inflammatory Response Syndrome Trial in Assiut (solumedrol, Dexamethasone phosphate)

Completed
  • Systemic Inflammatory Response Syndrome
  • Assiut, Assuit, Egypt
    Assuit university hospital
Jun 11, 2021

Covid19 Trial in Worldwide (Infliximab, Abatacept, Remdesivir)

Completed
  • Covid19
  • Phoenix, Arizona
  • +90 more
May 3, 2022

Immune Modulators and IVF

Terminated
  • In Vitro Fertilization
  • Observational
  • New York, New York
    Ronald O. Perelman and Claudia Cohen Center for Reproductive Med
Sep 11, 2019

Detection and Characterization of Host Defense Defects

Recruiting
  • Immune Defects
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Glioblastoma Multiforme of Brain, Glioblastoma Multiforme Trial in Shenzhen (Antigen-specific IgT cells)

    Enrolling by invitation
    • Glioblastoma Multiforme of Brain
    • Glioblastoma Multiforme
    • Antigen-specific IgT cells
    • Shenzhen, Guangdong, China
    • +1 more
    Nov 23, 2021

    Immune-mediated Diseases

    Recruiting
    • Primary Immunodeficiency
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 10, 2023

      Epileptic Seizures Related to Drugs Trial in Xi'an (minocycline)

      Enrolling by invitation
      • Epileptic Seizures Related to Drugs
      • Xi'an, Shaanxi, China
        XijingHospital
      Jul 21, 2023

      Psoriasis Trial (Roflumilast, Methotrexate)

      Not yet recruiting
      • Psoriasis
      • (no location specified)
      Jan 5, 2023

      Glioblastoma Trial in Atlanta, Bethesda (Nivolumab, BMS-986016)

      Recruiting
      • Glioblastoma
      • Atlanta, Georgia
      • +1 more
      Sep 21, 2022

      Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative

      Completed
      • Colitis, Ulcerative
      • No Intervention
      • Ansan-si, Korea, Republic of
      • +14 more
      Mar 30, 2022

      MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

      Not yet recruiting
      • MSS
      • Rectal Cancer
      • Sintilimab with Interleukin-2
      • (no location specified)
      Nov 1, 2023

      Celiac Disease Trial in Redwood City (PTG-100, Placebo)

      Completed
      • Celiac Disease
      • Redwood City, California
        Stanford University
      May 19, 2022

      COVID-19 Vaccine Response in Treated MS Patients

      Recruiting
      • Multiple Sclerosis
      • Healthy
      • Blood draw
      • Boston, Massachusetts
        Brigham MS Center
      Jul 26, 2022

      Renal Cancer Metastatic Trial in Reggio Emilia (Nivolumab)

      Completed
      • Renal Cancer Metastatic
      • Reggio Emilia, Italy
        Struttura Complessa di OncologiaIRCCS- Istituto in Tecnologie Av
      May 1, 2022

      Colorectal Cancer Trial in China (Huaier granule)

      Not yet recruiting
      • Colorectal Cancer
      • Huaier granule
      • Harbin, Heilongjiang, China
      • +8 more
      Oct 15, 2023

      Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

      Active, not recruiting
      • Glioblastoma Multiforme
      • Stanford, California
      • +1 more
      Nov 22, 2022

      Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,

      Not yet recruiting
      • Refractory or Recurrent Solid Tumor
      • Spartalizumab in Pediatric cohort
      • +3 more
      • Angers, France
      • +8 more
      Mar 9, 2022

      MicroRNAs and Cytokines in Peri-Implantitis Tissue

      Active, not recruiting
      • Peri-implantitis
        • Baghdad, Iraq
          Munir
        Mar 14, 2023

        Gulf War Illness Trial in Birmingham (Boswellia Serrata, Curcumin, Epimedium)

        Active, not recruiting
        • Gulf War Illness
        • Boswellia Serrata
        • +9 more
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Nov 17, 2021

        Glioma, Glioblastoma Trial in United States (drug, radiation, procedure)

        Recruiting
        • Glioma
        • Glioblastoma
        • Phoenix, Arizona
        • +3 more
        Oct 13, 2022